NCI—H929.docVIP

首页 产品目录 细胞株_肿瘤细胞 肿瘤细胞_人类肿瘤细胞系目录 产品[CRL-9068 NCI-H929 人骨髓瘤细胞株]资料 首页 产品目录 细胞株_肿瘤细胞 肿瘤细胞_人类肿瘤细胞系目录 CRL-9068 NCI-H929 人骨髓瘤细胞株 给我留言 产品名称: CRL-9068 NCI-H929 人骨髓瘤细胞株简单介绍 CRL-9068 NCI-H929 人骨髓瘤细胞株，原代细胞|细胞系|细胞株|菌种；细胞库管理规范，提供的细胞株背景清楚，提供参考文献和最优培养条件！CRL-9068 NCI-H929 人骨髓瘤细胞株 的详细介绍 CRL-9068 NCI-H929 人骨髓瘤细胞株 ATCC? Number: CRL-9068? Price: $309.00 Designations: NCI-H929 [H929] Depositors: ?National Cancer Institute Isotype: IgA kappa Recent tests for IgA, kappa have not detected the production of IgA; the cells are producing kappa light chain. Biosafety Level: 1 Shipped: frozen Medium Serum: See Propagation Growth Properties: suspension Organism: Homo sapiens human Morphology: lymphoblast Source: Organ: bone marrow Disease: plasmacytoma; myeloma Cell Type: B lymphocyte; Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location. Receptors: transferrin Antigen Expression: PCA-1; CD38 + DNA Profile STR : Amelogenin: X CSF1PO: 11 D13S317: 12 D16S539: 9,13 D5S818: 11,12 D7S820: 10,12 THO1: 9.3 TPOX: 8,11 vWA: 14,15 Cytogenetic Analysis: Near tetraploid. Most copies of chromosome 8 have the 8q+ abnormality. Age: 62 years Gender: female Ethnicity: Caucasian Comments: This cell line was established from a malignant effusion in a patient with myeloma. The cells are positive for plasma cell antigen 1 PCA-1 , transferrin receptor, CD38 T10 , but are negative for HLA DR, CALLA and markers of early B cell development. They are negative for Epstein-Barr virus nuclear antigen EBNA . The cells have a rearrangement of the c-myc proto oncogene and express c-myc RNA. There is also an activated ras allele. Propagation: ATCC complete growth medium: The base medium for this cell line i